Morocco has to look for new COVID-19 vaccine batches from other suppliers and forget about the AstraZeneca vaccine for at least a month, after Indian authorities decided to delay the delivery of new vaccine shipment to the world, according to Reuters, quoting informed Indian sources.
Reuters said today that the Serum Institute of India, which is specialized in the production of the AstraZeneca-Oxford vaccine, will devote its production from the vaccine for India after occurring a surge in Coronavirus cases within the country.
Vaccine deliveries for other countries, such as Morocco, Brazil, and Saudi Arabia, will be delayed in March and April, Reuters reported.
This step from India also affects the shipments of vaccine that has been devoted for the World Health Organization under the COVAX initiative that was created by WHO to help poor countries to get a quantity of vaccine to start their campaigns against covid-19.
The Moroccan health authorities have to look for other vaccine maker companies to get sufficient vaccine doses in order to continue the national vaccination campaign. Johnsons and Johnson, besides Sputnik V, are two COVID-19 vaccines that are lately being approved to use in the Moroccan campaign.
More than 4 million people have already been vaccinated in Morocco so far, after securing 8 million and a half million doses, 7 million doses of AstraZeneca-Oxford vaccine, and 1 million and a half million doses of the Chinese Sinofarm vaccine.
Morocco has slowed the vaccination campaign in the last few days, waiting for other supplies, and sources from Health Ministry have recently said that new shipments of vaccine will arrive in Morocco in late March and the beginning of April; they could be from Russia or China.